Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes

NCT01968265 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ISIS-GCCRRx
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.